Artixio

Medical Devices Regulatory Services In Mexico

Your regulatory partner for MedTech services in Mexico, from concept to market.

Artixio provides seamless regulatory services for commercialization of your medical device in the Mexican market. Our experienced local team in Mexico helps you navigate through the stringent guidelines of COFEPRIS and achieve timely compliance. We aim at helping our clients right from product conceptualization until product surveillance.

Services

Regulatory Intelligence & Strategy

MDR Gap Assessment

Medical Device Regulatory Affairs

Quality Consulting

Technical and Medical Writing

Clinical, Performance Evaluation

Medical Device Registration / Certification

Authorized Agent / Legal Representation

Post Market Surveillance

Key Regulations for Medical Devices in Mexico

General Health Law
Regulation of Health Supplies

Classification Of Medical Devices

In Mexico, devices are classified to Class I, II and III depending on their risk level. Class I devices have low risk to patients, while Class III devices are high risk, complex devices. However, all three classes require approval from the COFEPRIS. Class I requires minimal documents; class II requires moderate documents whereas class III requires stringent in-depth documents.

Process For Registration Of Medical Devices In Mexico

Documents Required For Medical Device Registration In Mexico

Artixio’s Medical Devices Registration Services in Mexico

Our Regulatory and Market Access experts based in Mexico, coupled with the Global Regulatory Projects team, have assisted over a hundred pharmaceutical, medical devices, diagnostics, cosmetics, nutraceuticals, supplements, and veterinary products successfully register and maintain compliance with COFEPRIS in Mexico. Coupled with the Artixio’s intelligence-based services platform, Dvarka, innovators and manufacturers around the globe have benefited by seamlessly managing the regulatory strategy for the product development and commercialization value chain.
For Medical Devices, from strategic planning and registration to post-market compliance, Artixio provides high-quality efficient regulatory affairs services to support your business in Mexico.

Why Artixio?

Local experienced staff with 15-35+ years of experience in Mexico
Regulatory intelligence driven strategies.
End to End Support from Product Conceptualization to Launch and Post Market Support
Tailored regulatory solutions for COFEPRIS compliance
Ensuring compliance for 200+ Devices and Diagnostics Products Licenses
Customer focused timely compliance with COFEPRIS guidelines
ISO 9001:2015, Quality Driven Services Platform
Flexible Business Models – Project Based; Long Term FTE based

FAQs

Is it necessary to appoint a local representative in Mexico for medical device commercialization?
Yes, it is mandatory for the foreign manufacturers to appoint a local representative for the regulatory procedures of their medical device.
No, the clinical trial requirement depends upon the complexity of the class of device.
The label on the medical device should be written in Spanish language and must comply with the NOM-137-SSA1-2008 standards.
The medical device registration is valid for a period of 5 years, which should be renewed before its expiry to keep the registration valid.

Regulatory Expertise Across
Multiple Countries

India
Vietnam
Mexico​
Vietnam
United States
Brazil
Europe
Malaysia
Taiwan
China
Thailand
Philippines

Industries we serve

Pharmaceuticals

Cosmetics

Nutrition

Medtech

Biologics

Veterinary

Blogs

In Vitro Diagnostics: Meaning, Types And Benefits

In Vitro Diagnostics: Meaning,

The term “in vitro” is a Latin word that means “in glass”. Thus, from...

June 20, 2025
IVD Medical Devices Registration & Approval In India

IVD Medical Devices Registration

The in vitro diagnostic in India is regulated by the Central Drugs Standard Control...

June 17, 2025
Pharma Manufacturing Booms in Hidalgo, Mexico

Pharma Manufacturing Booms in

Once overlooked pharma hub in Mexico's Hidalgo region has gained importance with global market...

June 18, 2025